MedPath

Antibiotic resistant (ABR) hotspots in the population of Rotterdam: a feasibility study for a future population-based prevalence study

Conditions
antibiotic resistance - resistant bacteria
10002252
Registration Number
NL-OMON43243
Lead Sponsor
GGD Rotterdam-Rijnmond
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1. Adult (18 years and older)
2. Physically and mentally able to consent and participate (capacitated)
3. Resident of Rotterdam
4. Officially enrolled in the GP practice where enrollment takes place
5. Provides informed consent

Exclusion Criteria

All those not eligible according to the inclusion criteria. Additionally, a potential subject who shows inability to communicate with the research team in Dutch or otherwise, will also be excluded from the participation in the study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p> Prevalence (%) of antibiotic resistant E. coli, S. aureus and K. pneumoniae<br /><br>strains in a population sample of residents of Rotterdam.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Associations between the presence of antibiotic resistance and riskfactors such<br /><br>as age, sex, travel history, antibiotic use, hospital admissions and workplace.</p><br>
© Copyright 2025. All Rights Reserved by MedPath